MedPath

GLAUrious long-term follow-up study of glaucoma laser treatment

Not Applicable
Conditions
Glaucoma
Eye Diseases
Registration Number
ISRCTN96782911
Lead Sponsor
BELKIN Vision
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
192
Inclusion Criteria

Participants enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021

Exclusion Criteria

Participants who were not enrolled to the GLAUrious study and treated with either the SLT or DSLT between November 2018 and May 2021

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety parameters (slit lamp exam). This observational study includes only one single visit.
Secondary Outcome Measures
NameTimeMethod
Additional safety parameters (IOP, visual field, and fundus exam). This observational study includes only one single visit.
© Copyright 2025. All Rights Reserved by MedPath